Target intelligence / Profile preview

MicroRNA 4269 (MIR4269)

Target
MIR4269
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

MicroRNA 4269 (MIR4269) is a human microRNA classified as a non-coding RNA involved in post-transcriptional gene silencing. It exerts tumor suppressor functions in cancer by directly binding the 3′-UTR of oncogenic transcription factors TEAD1 and TEAD4, thus repressing their expression. Downregulation of MIR4269 is associated with poor cancer-specific survival. MIR4269, like other microRNAs, is processed from a stem-loop precursor by Dicer, loaded into the RNA-induced silencing complex (RISC), and guides the complex to target mRNAs primarily in the 3′UTR. MIR4269 may also be implicated as a biomarker for disease and patient stratification

Other names
MIR4269hsa-mir-4269
02

Mechanism of action

Drugs or therapeutic approaches targeting microRNAs generally act by mimicking or inhibiting miRNA function, which leads to the restoration or suppression of tumor-suppressive or oncogenic regulatory pathways

03

Biological functions

Post-transcriptional regulation of gene expressionmRNA destabilization or translational inhibitionTumor suppression via inhibition of oncogenic factors (notably TEAD1 and TEAD4 in gastric cancer)
04

Disease associations

Cancer (specifically gastric cancer where its downregulation is linked to poor prognosis)Brachydactyly (as indicated by GeneCards disease associations)
05

Safety considerations

Off-target effects and immune system modulation are general concerns when therapeutically modulating miRNAsSpecific safety data for MIR4269 interventions are not available
06

Biomarkers

Circulating miRNAs (including MIR4269) can serve as non-invasive biomarkers for disease diagnosis or prognosisDownregulation of MIR4269 as a biomarker of poor survival in cancer

Beyond the preview

Go deeper on MicroRNA 4269 (MIR4269).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4269 (MIR4269).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call